Clinical Trial Update: ATAC - Bone Density Sub-Protocol [Phase 3]

View source ↗

Summary

Phase 3 ATAC trial's bone density sub-protocol has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• ARIMIDEX (anastrozole)
• Tamoxifen (tamoxifen)

Snippet

Sponsor: AstraZeneca | Conditions: Bone Density | Phase 3 | Status: COMPLETED